ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Valneva SE

Valneva SE (VLA)

1.822
0.037
(2.07%)
Cerrado 03 Diciembre 10:30AM

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Estadísticas y detalles clave

Último Precio
1.822
Postura de Compra
1.802
Postura de Venta
1.839
Volume Operado de la Acción
1,055,522
1.803 Rango del Día 1.909
1.781 Rango de 52 semanas 5.438
Capitalización de Mercado [m]
Precio Anterior
1.785
Precio de Apertura
1.822
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
587,111
Acciones en circulación
138,202,132
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.48
Beneficio por acción (BPA)
-0.73
turnover
175.73M
Beneficio neto
-101.43M

Acerca de Valneva SE

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Saint-herblain, Loire-atlantique, Fra
Fundado
-
Valneva SE is listed in the Pharmaceutical Preparations sector of the Euronext with ticker VLA. The last closing price for Valneva was 1.79 €. Over the last year, Valneva shares have traded in a share price range of 1.781 € to 5.438 €.

Valneva currently has 138,202,132 shares in issue. The market capitalisation of Valneva is 246.69 € million. Valneva has a price to earnings ratio (PE ratio) of -2.48.

VLA Últimas noticias

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ® Antibody levels remained high at 96% seroresponse in line with the two-year...

Valneva annonce des données positives sur la persistance des anticorps à trois ans pour son vaccin à dose unique contre le chikungunya, IXCHIQ®

Valneva annonce des données positives sur la persistance des anticorps à trois ans pour son vaccin à dose unique contre le chikungunya, IXCHIQ® Les niveaux d’anticorps demeurent élevés avec un...

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

Antibody levels remained high at 96% seroresponse in line with the two-year persistence data This long-lasting antibody persistence was comparable in older (65+) and younger adults Saint-Herblain...

Valneva soumet à la FDA une demande d’extension d’indication pour son vaccin contre le chikungunya IXCHIQ®

Valneva soumet à la FDA une demande d’extension d’indication pour son vaccin contre le chikungunya IXCHIQ® Avec pour objectif l’extension de l’utilisation aux adolescents et l’inclusion de la...

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

To potentially include adolescents and antibody persistence up to two years Saint Herblain (France), November 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine...

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA To potentially include adolescents and antibody persistence up to two years Saint Herblain...

Valneva et LimmaTech annoncent la vaccination du premier participant à l’essai d’infection contrôlée de Phase 2b du candidat vaccin tétravalent contre la shigellose S4V2

Valneva et LimmaTech annoncent la vaccination du premier participant à l’essai d’infection contrôlée de Phase 2b du candidat vaccin tétravalent contre la shigellose S4V2 Saint Herblain (France) et...

Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2

Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2 Saint Herblain (France) and Schlieren (Zurich), November 13, 2024...

Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2

Saint Herblain (France) and Schlieren (Zurich), November 13, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage...

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Saint-Herblain (France), November 12, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.198-9.801980198022.022.021.7818156711.84980471DE
4-0.826-31.19335347432.6482.711.7816237022.1008178DE
12-1.258-40.84415584423.083.21.7815871112.47940497DE
26-2.424-57.08902496474.2464.2981.7815398012.96995427DE
52-3.478-65.62264150945.35.4381.7815293083.37871109DE
156-24.098-92.970679012325.9227.51.7815782709.25830367DE
260-0.683-27.26546906192.50529.71.78167445210.93199597DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ALVETEGEIRO Pharma
0.124 €
(58.97%)
481.8k
ALDVAlliance Developpement Capital Siic
0.074 €
(32.14%)
6k
MLSRPSpeed Rabbit Pizza
8.20 €
(30.16%)
19
MLSEQSequa Petroleum NV
0.011 €
(29.41%)
12k
MLCOTCoretech 5
0.01 €
(-41.18%)
200
ATOAtos SE
0.495 €
(-32.65%)
17.92M
AFMEAffluent Medical
1.20 €
(-21.05%)
21.92k
ALBIOBiosynex
2.095 €
(-18.32%)
26.9k
TRACTTeract SA
1.03 €
(-15.23%)
76.91k
BCPBanco Comercial Portugues SA
0.4457 €
(2.20%)
44.64M
ALNEVNeovacs
0.0003 €
(0.00%)
33.59M
ATOAtos SE
0.495 €
(-32.65%)
17.92M
ALCYBCybergun
0.0002 €
(100.00%)
10.06M
ORAOrange.
9.706 €
(-2.99%)
9.65M
1vman 1vman 1 minuto hace
***** 🤪Huge🚽UBQU🚽share structure here - VERY concerning

ENOUGH SAID HUZZAH🤪 !!!
UBQU
Investor082 Investor082 2 minutos hace
Phunware stock is pretty much unchanged since the decision. Ultimately, none of this matters except execution, and institutional investor support. NWBO will continue to struggle in both departments. One month away from UK approval and still no hiring! Tells you all you need to know about whats comin
NWBO
TradingCharts TradingCharts 2 minutos hace
Are there any permits in ND or Montana for lithium brine sampling or lithium extraction?

Copilot
Yes, there are permits for lithium brine sampling and extraction in both North Dakota and Montana.

North Dakota
In North Dakota, lithium exploration in the Wil
IBATF
Lime Time Lime Time 2 minutos hace
Nobody dumping end of year yet.
CNNA
mrfence mrfence 2 minutos hace
BUY the GSE'shttps://ichef.bbci.co.uk/news/1024/cpsprodpb/14919/production/_114094248_gettyimages-1161698552.jpg.webp
Before we set them FREE's
$FMCC~ $FMNA~
FMCC FMNA
HoldEm777 HoldEm777 2 minutos hace
Exactly. I genuinely like a lot of those people still today… but they could give two shits about me or my family and when I finally realized that I was able to separate things. Things become a lot more clear.
RDAR
williams45 williams45 3 minutos hace
In the future, $NNVC could be the gold standard in virology.

https://profiles.smallcapsdaily.com/nnvc/
NNVC
drink-up drink-up 4 minutos hace
Did you call him and ask? I doubt anyone on here has an answer to that question.
APRU
ph3r ph3r 4 minutos hace
Not related to this stock but came across this article earlier today.  Legit?

https://scitechdaily.com/scientists-discover-a-way-to-shrink-quantum-computer-components-by-1000x/
IONQ
weedtrader420 weedtrader420 4 minutos hace
SUKU XRP 😉🤑
XRPUSD
iclight iclight 5 minutos hace
The MHRA waiting for information from an RFI that NWBO can not give or does not want to give is not a material event.

"Please proved the patient level data for your external control arm."

If NWBO does not respond they can continue to dump shares and pay for Advent while
NWBO
Dead On Arrival Dead On Arrival 5 minutos hace
Scope, how do you double down in June on guidance and then miss that timeline. Who is the go between LWLG and the foundries. They knew the investment community was leery of their credibility and yet they put that out. You do not do that. Lebby might be a genius in the tech world but he is a ****ing
LWLG
1vman 1vman 5 minutos hace
*****🚽HCMC🚽 65.5 -Million XPERT Sells as the bail out continues merrily along

https://ih.advfn.com/stock-market/USOTC/healthier-choices-manage-pk-HCMC/trades

ENOUGH SAID HUZZAH🤪!!!
HCMC
Lone Clone Lone Clone 5 minutos hace
Taranis Engages Novus Engineering to Complete Engineering Work for Bulk Sample at Thor

https://www.accesswire.com/949734/taranis-engages-novus-engineering-to-complete-engineering-work-for-bulk-sample-at-thor

Tuesday, 03 December 2024 01:35 PM

ESTES PARK,
RIGATONI RIGATONI 5 minutos hace
This one getting some volume and ^ tick...

TOGI .02

recently.. https://www.otcmarkets.com/stock/TOGI/news/story?e&id=3059748
TOGI
PEMBROKE1 PEMBROKE1 5 minutos hace
Hi, I remember back then I said that SIRC should become a Law Firm.

There is nothing in particular I am looking for in the Quarterly 3 filing if there is one.
Just curios on SIRC's next move.
SIRC
BullNBear52 BullNBear52 5 minutos hace
Obviously I bought back genius. As for the bills? What are those? Your problem is you think you know something about a poster when you are actually clueless.

I haven't touched a dime of retirement income but next year that will change since I'll be 73. And I worked till I was 69 1/2 a
StayHumble StayHumble 5 minutos hace
✅16 Million+ XPERT BUYS $HIRU💹💹💹https://ih.advfn.com/stock-market/USOTC/hiru-pk-HIRU/trades
HIRU
Biotechotcguy Biotechotcguy 5 minutos hace
Until we meet again 🤞🏽
BLPG
Master-of-Disaster Master-of-Disaster 5 minutos hace
Nice job frontloading $BTZI, now keep it going...
BTZI
NASDAQ2020 NASDAQ2020 6 minutos hace
HammerTime !!!!!!!!!!!!!!!!
AMMX
NickyCapone NickyCapone 6 minutos hace
https://share.icloud.com/photos/0fdrT8DHe-H4nA-neA3npsVSQ
AMC
TradingCharts TradingCharts 6 minutos hace
Lithium royalties for North Dakota and Montana

copilot
In North Dakota and Montana, the royalties for lithium extraction can vary based on lease agreements and negotiations. Here are some general insights:

North Dakota
Royalty Rates: The royalty rates for
IBATF
StayHumble StayHumble 6 minutos hace
💹GreensNaturalFoods💹doubles $HCWC💹Revenue to $73Million+✅ @healthiercmc
https://www.healthiercmc.com/news/20221017-greens-natural-foods


https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/166681727316
HCWC
Zorax Zorax 6 minutos hace
Everything you wrote is fully accurate. However, the statute of limitations on the cases with no immunity is up after 2028, whereas if charges are reinstated now, the cases could conceivably go forward in the next few years IF and only IF a AG removes the sitting shitface law. Otherwise obviously it

Su Consulta Reciente

Delayed Upgrade Clock